Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

China flag China · Delayed Price · Currency is CNY
14.76
-0.57 (-3.72%)
Jun 11, 2026, 1:24 PM CST
Market Cap3.36B -19.2%
Revenue (ttm)265.79M -26.0%
Net Income-13.18M
EPS-0.06
Shares Out 219.45M
PE Ration/a
Forward PEn/a
Dividend1.20 (7.75%)
Ex-Dividend DateJun 12, 2025
Volume1,183,717
Open15.43
Previous Close15.33
Day's Range14.76 - 15.43
52-Week Range14.76 - 23.28
Beta0.30
Analystsn/a
Price Targetn/a
Earnings DateSep 1, 2026

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China. [Read more]

Sector Healthcare
Founded 2008
Employees 599
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002932
Full Company Profile

Financial Performance

Financial Statements